EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines

Authors

Institutions

Publication Details

Journal
Epigenomics
Published
2025-01-29
DOI
https://doi.org/10.1080/17501911.2025.2453419
Citations
3
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
2.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines

Cheryl A. Hawkes, Mark Eccleston, Irene Fischetti, Vera Mongiardini et al.
3 citations
Epigenomics
Epigenetics and DNA Methylation
2.42
article

EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines

Cheryl A. Hawkes, Mark Eccleston, Irene Fischetti, Vera Mongiardini, Massimiliano Manzo, Francesco Crea, Maryam Latarani, Elena Jachetti, Sushilaben H. Rigas, Ilaria Alborelli, Namra Mahmood, Priyadarsini Gangadharannambiar, Shusuke Akamatsu, Mario P. Colombo, Benedetto Grimaldi, Perla Pucci, Yuzhuo Z. Wang
article en
3 citations

Abstract

No abstract available for this paper.
EpigenomicsVol. 17(3)
University of British Columbia (CA), University of Basel (CH), The Open University (GB), University of Cambridge (GB), University Hospital of Basel (CH), Italian Institute of Technology (IT), ValiRx (United Kingdom) (GB), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Nagoya University (JP), Lancaster University (GB)
Prostate Cancer UK
Good health and well-being
Openalex Percentile: Top 13%
Epigenetics and DNA Methylation
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines — Cheryl A. Hawkes, Mark Eccleston, et al. · Epigenomics (2025) | TGRS Research Map | TGRS